These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2409815)

  • 21. Effect of proglumide on rat pancreatic growth.
    Yamaguchi T; Tabata K; Johnson LR
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
    Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
    Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
    Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
    Varga G; Papp M; Scarpignato C
    Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proglumide analogues: potent cholecystokinin receptor antagonists.
    Jensen RT; Murphy RB; Trampota M; Schneider LH; Jones SW; Howard JM; Gardner JD
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G214-20. PubMed ID: 2411147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.
    Verspohl EJ; Wunderle G; Ammon HP; Williams JA; Goldfine ID
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):284-7. PubMed ID: 3012373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
    Hahne WF; Jensen RT; Lemp GF; Gardner JD
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6304-8. PubMed ID: 6171817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of CCK antagonists CR 1409 and CR 1505 on rat pancreatic exocrine secretion in vivo.
    Shiratori K; Shimizu K; Watanabe S; Takeuchi T; Moriyoshi Y
    Pancreas; 1989; 4(6):744-50. PubMed ID: 2813333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of stimulated amylase secretion by adrenomedullin in rat pancreatic acini.
    Tsuchida T; Ohnishi H; Tanaka Y; Mine T; Fujita T
    Endocrinology; 1999 Feb; 140(2):865-70. PubMed ID: 9927317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
    Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.
    Stubbs RS; Stabile BE
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G347-52. PubMed ID: 2858160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intrinsic CCK and CCK antagonist on pancreatic growth and pancreatic enzyme secretion in pancreaticobiliary diversion rats.
    Bamba T; Ishizuka Y; Hosoda S
    Dig Dis Sci; 1993 Apr; 38(4):653-9. PubMed ID: 7681747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
    Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
    J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic digestive enzyme secretion in the rabbit: rapid cyclic variations in enzyme composition.
    Adelson JW; Clarizio R; Coutu JA
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2553-7. PubMed ID: 7535925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of proglumide on pancreatic endocrine and exocrine function in healthy humans.
    Funakoshi A; Nakano I; Shinozaki H; Miyazaki K; Ibayashi H
    Regul Pept; 1987 Jun; 17(6):311-8. PubMed ID: 3299507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulatory effect of N-methyltyramine, a congener of beer, on pancreatic secretion in conscious rats.
    Tsutsumi E; Kanai S; Ohta M; Suwa Y; Miyasaka K
    Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S14-7. PubMed ID: 19298333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel micromethod for pancreatic acinar secretion. Time course of CCK stimulation and its inhibition by L-364,718.
    Adrian TE; Zucker KA; Bilchik AJ; Modlin IM
    Int J Pancreatol; 1990 Jan; 6(1):61-9. PubMed ID: 1700032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of endogenous cholecystokinin on vagally stimulated pancreatic secretion in dogs.
    Kim CK; Lee KY; Wang T; Sun G; Chang TM; Chey WY
    Am J Physiol; 1989 Dec; 257(6 Pt 1):G944-9. PubMed ID: 2481981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.